A jury in Louisiana has awarded more than $9 billion in the first federal bellwether trial over claims that taking Actos increases the risk of getting bladder cancer.

The jury’s verdict, the first of nearly 3,000 lawsuits coordinated for pretrial purposes before U.S. District Judge Rebecca Doherty in Lafayette, La., emerged late Monday after nearly two months of trial.